COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...

Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

After a well-reviewed emcee debut, the Golden Globes are bringing back comedian Nikki Glaser to host the 2026 ceremony.

The exact price depends on dosage, pharmacy, location, insurance coverage, and available savings programs. Fully understanding the various factors affecting ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.